Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Weekly tablet that strengthens bones. | Twice-yearly bone-strengthening injection. |
| Body system | Hormones & Bones | Hormones & Bones |
| Drug class | Bisphosphonates | RANKL inhibitors |
| Supply | Prescription only | Prescription only |
| Main uses | Osteoporosis, Steroid-induced osteoporosis, Paget's disease | Osteoporosis, Bone loss from hormone cancer treatment, Preventing fractures from bone metastases |
| How it works | Slows the cells that break bone down, so bone becomes denser. | Blocks the signal that switches on bone-dissolving cells. |
| Starts working | — | — |
| Half-life | Over 10 years in bone | About 26 days |
| Typical adult dose | 70 mg once a week. | Osteoporosis: 60 mg under the skin every 6 months. |
| Forms | Tablet, Effervescent tablet, Oral solution | Pre-filled syringe |
| Common side effects | Heartburn, Stomach pain, Muscle and bone aches | Joint and muscle pain, Back pain, Eczema |
| Serious side effects | Oesophageal ulcers, Jaw osteonecrosis (rare), Atypical thigh fractures (rare, long-term use) | Low calcium (severe in advanced kidney disease), Rebound spinal fractures if doses are missed, Jaw osteonecrosis (rare) |
| Don't take if | Oesophageal problems (strictures, achalasia); Cannot sit or stand upright for 30 minutes; Low calcium; Severe kidney impairment (eGFR below 35) | — |
| Alcohol | Best to limit. Alcohol irritates the gullet and bones. | — |
| Pregnancy | Usually avoidedNot used. | Usually avoidedContraindicated. |
| Breastfeeding | Usually avoidedAvoid. | — |
| In use since | 1995 | 2010 |
| Brand names | United States: Fosamax, BinostoUnited Kingdom: FosamaxIndia: Osteofos, Densical | United States: Prolia, Xgeva, Jubbonti (biosimilar)United Kingdom: Prolia, XgevaIndia: Prolia, Denosure |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | M05BA04 | M05BX04 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker